| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Revenue increased 10% to $54.8 billion GAAP1 operating loss was $14 million and GAAP diluted EPS was $0.02, driven by a Medical segment goodwill impairment Non-GAAP operating earnings increased 35% to
Read more about The Harvard Drug Group, LLC Issues Voluntary Nationwide Recall of Certain Rugby® Laboratories Brand Eye Drops Supplied by Velocity Pharma, LLC Due to Potential Risk of Eye Infections
Read more about Cardinal Health, Inc. Issues Voluntary Nationwide Recall of Certain LEADER™ Brand Eye Drops Supplied by Velocity Pharma, LLC Due to Potential Risk of Eye Infections
Cardinal Health (NYSE: CAH) has been named among the 100 Best Corporate Citizens, a prestigious annual ranking by 3BL Media that assesses the environmental, social and governance (ESG)...
Read more about Cardinal Health Named to 100 Best Corporate Citizens of 2023
The next generation in enteral feeding, Kangaroo OMNI™ delivers nutrition and hydration from hospital to home. DUBLIN, Ohio, Sept. 28, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced...
Read more about Cardinal Health Launches Kangaroo OMNI™ Enteral Feeding Pump
Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2024 on November 3, prior to the opening of trading on the New York Stock Exchange. The company...
Read more about Cardinal Health to Announce First-Quarter Results for Fiscal Year 2024 on November 3
Cardinal Health Foundation will invest $1.7M to help 14 children's hospitals nationwide prevent youth suicide. DUBLIN, Ohio, Sept. 13, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) in...
The NTrainer™ System 2.0 is the only FDA Class II biofeedback device designed to help newborns and infants born prematurely develop their non-nutritive sucking skills needed for independent oral...
Read more about Cardinal Health Launches Next Generation Medical Device to Improve Neonatal Feeding
Fourth quarter revenue increased 13% to $53.5 billion Fourth quarter GAAP1 operating earnings were $137 million and GAAP diluted loss per share was $0.25 Fourth quarter non-GAAP operating earnings...
Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5006 per share out of the Company's capital surplus. The dividend will be payable on...
Read more about Cardinal Health Board of Directors Approves Quarterly Dividend